Filing Details
- Accession Number:
- 0001371285-20-000067
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-13 19:53:35
- Reporting Period:
- 2020-04-09
- Accepted Time:
- 2020-04-13 19:53:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1371285 | Trupanion Inc. | TRUP | Hospital & Medical Service Plans (6324) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1800776 | Gavin Friedman | 6100 4Th Avenue S Suite 200 Seattle WA 98108 | Chief People Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-04-09 | 6,000 | $16.32 | 8,457 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-04-09 | 6,000 | $30.00 | 2,457 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2020-04-09 | 6,000 | $0.00 | 6,000 | $16.32 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,000 | 2026-09-19 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on February 18, 2020, in order to implement a plan of financial diversification. Accordingly, thereporting person had no discretion with regard to the timing of the transaction.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.115 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
- The option vested as to 25% of the total shares on September 12, 2017, and then 2.0833% of the total shares vested monthly thereafter, with 100% of the total shares vested and exercisable on September 12,2020, subject to continued service through each vesting date.